Filing Details
- Accession Number:
- 0001415889-21-004862
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-13 16:00:52
- Reporting Period:
- 2021-10-11
- Accepted Time:
- 2021-10-13 16:00:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477845 | Annovis Bio Inc. | ANVS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1315018 | Maria-Luisa Maccecchini | C/O Annovis Bio, Inc. 1055 Westlakes Drive, Suite 300 Berwyn PA 19312 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-11 | 18,000 | $27.61 | 976,775 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.58 to $27.64, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.